Helpline 07939 046 030
Freephone 0300 102 17 22*

Georgia’s Story

08 October 2024

I was diagnosed with Neurofibromatosis Type1 (NF1) at nine years of age after a visit to the doctor, which was prompted by concerns related to reoccurring joint and abdominal pains, headaches, disrupted sleep, and vision impairment. Following this, the doctor made a referral to Alder Hey Hospital in Liverpool, where a specialist promptly confirmed the diagnosis of the condition, with my café-au-lait marks being the most prominent verification. To the best of my current knowledge and that of my family, I am the sole individual within our family affected by NF1, resulting from a spontaneous mutation of the gene.

Growing Up, I struggled to come to terms with my condition and often asked, Why me?

Growing up, I struggled to come to terms with my condition and often questioned, 'Why me?' I was always embarrassed to admit that there was something 'different' about me due to things that happened at school. Bullying was a reality for me for most of my younger years, labels were unfortunately given to me, and school reports constantly remarked the same thing in relation to me being 'too chatty', 'being easily distracted' and having 'no coordination'. It felt like no one at school (more so at secondary school) understood me. I was often told off for things I truly had no control over.

My parents repeatedly had to explain my condition to my teachers and why sometimes I'd have to miss school due to sickness or appointments. My mum even remembers having to fill in forms at the start of every school year and having to re-explain my condition over and over at parents' evening. An NF1 specialist and my counsellor even had to visit my secondary school at one time as teachers still didn't seem to understand oreven acknowledge it.

If someone had told me when I was younger, that I would be able to talk about this so openly and confidently, I would never have listened to them

I often had to undergo laser surgery for hypertrichosis, which is what people would point out and ridicule me for the most. This is excessive pigmentation and hair growth on the skin, and mine appeared on my forehead. I used to go to the most extreme lengths to hide and cover it up. If someone had told me when I was younger, that I would be able to talk about this so openly and confidently, I would never have believed them, but I now realise the bullying was not a reflection on me, or who I am and never will be. I went through most of my compulsory education years with undiagnosed Attention Deficit Hyperactivity Disorder (ADHD), which ultimately made my journey a lot harder, and up until the age of 16 (when I was diagnosed and had officially left school), I often blamed myself for things that had happened. I received counselling for a number of years in regard to self-image and how 'I went about things'. I was even under Tier 3 mental health services at one point, which I look back at now and can't believe how far I've come in my journey of accepting myself. I was lucky enough to have a very supportive family around me during this period.

"I finally found a space with dedicated specialists who understood me and a community with other patients and families affected by NF1 who cared, listened, and offered advice"

I discovered Nerve Tumours UK (NTUK) after having one of the biggest health scares I ever had in 2020; I was told something had grown on my brain, which led to me becoming severely unwell during this period. I was even having fits, which, until this period and discovering this charity, I didn't even know was linked to my condition. However, I finally found a space with dedicated specialists who understood me and a community with other patients and families affected by NF1 who cared, listened, and offered advice. All those negative experiences I had when I was younger, suddenly didn't feel as important anymore. I'll always owe a great deal of gratitude for those who helped me through those dark times.

I decided to create a fundraiser for NTUK in 2021 after being inspired by all the amazing people who work so hard to fight for NF1 and all those people who fight with NF1 and raised
almost £700. Again, in 2023, that same horrible fear came back, but this time, it affected my ear, which led me to undergo surgery; still, my family, my friends and the NTUK charity and
support group gave me all the love and hope I needed until I once again heard the words 'all clear'.

NTUK has been such a safe and supportive place for me, and the people I've met along the way have genuinely changed my life. I always wanted to work with children upon leaving school to provide a positive learning experience (different from the one I had), embrace individuality, and end the stigma concerning disabilities, whether they are 'visible' or 'well-known' or not. After realising that other people from the NF1 community felt the same, after all the years of struggling and pleading to find answers, I decided to write my university dissertation on NF1: its wide spectrum; how it affects each individual differently and its need for recognition within education. I split my work into sections to be as informative as possible: the biology of NF1, the co-morbidities of NF1, the impacts of limited knowledge regarding NF1 and the educational difficulties, challenges and experiences of individuals with NF1.

Always embrace your uniqueness and consider it your superpower. There is strength in being different

After months of planning and researching, which proved very difficult due to the absence of established literature and research, I submitted my dissertation... and my work got a First (I even got a first overall in my degree,and an assignment of mine is now scholar work!) I was so happy and proud that NF1 had finally received recognition. I was also so happy and proud, that I went from dreading going to school and believing what people said about myself and my future, to having ambition and a love for education and not being afraid to speak about NF1. I’ve even taught English in Thailand, which was an opportunity that reinforced my love for learning and my passion to help others wherever I can. Going forward, I plan to continue spreading the word about NF1 and familiarising people with the condition, especially within educational settings and will use my dissertation as the basis of this.

I discovered Nerve Tumours UK (NTUK) after having one of the biggest health scares I ever had in 2020

Much to my younger self's surprise, now, I never question, 'Why me?' Instead, I embrace my condition. I understand my brain and body may sometimes work differently. NF1 makes me who I am. Living with NF1 has equipped me with resilience and confidence, fostering a determination to support others and communicate the message that prevailing over adversities is always possible, regardless of the challenges you may face. Always embrace your uniqueness and consider it your superpower. There is strength in being different and a lot of good that can be brought to the world by being just so.

Masterclasses in NF: Constitutional Mismatch Repair Deficiency Syndrome as Differential Diagnosis to NF1/Legius Syndrome - Prof. Dr. Katharina Wimmer

Constitutional Mismatch Repair Deficiency Syndrome as Differential Diagnosis to NF1/Legius Syndrome

Prof. Dr. Katharina Wimmer, Medical University of Innsbruck

Masterclasses in NF: Rare NF1-Associated Tumors in Adults - Eric Legius & Prof. Ellen Denayer

Masterclasses in NF: Rare NF1-Associated Tumors in Adults

Eric Legius, MD, PhD, University Hospital Leuven

Prof. Ellen Denayer, University Hospital Leuven

Masterclasses in NF: Optimising Hearing Outcomes in NF2-Related Schwannomatosis - Simon Freeman

Masterclasses in NF: Optimising Hearing Outcomes in NF2-Related Schwannomatosis

Simon Freeman, MPhil FRCS, Manchester Royal Infirmary and Salford Royal Hospital

Masterclasses in NF: NF1 Dermatological Manifestations - Pierre Wolkenstein, Laura Fertitta & Sirkku Peltonen

Masterclasses in NF: NF1 Dermatological Manifestations

Pierre Wolkenstein, MD, PhD, Hopital Henri-Mondor, Paris, France

Laura Fertitta, MD, Hôpital Universitaire Henri Mondor

Sirkku Peltonen, MD, PhD, University of Gothenberg, Sweden

Masterclasses in NF: Breast Cancer in NF1 - Gareth Evans

Masterclasses in NF: Breast Cancer in NF1

Gareth Evans, MD, University of Manchester, UK

Masterclasses in NF: Pain in Non-NF2-Related Schwannomatosis - David Pang

Masterclasses in NF: Pain in Non-NF2-Related Schwannomatosis

David Pang, MD, ChB. Guys and St Thomas' Hospital NHS Trust, London

Masterclasses in NF: Distinguishing Non-NF2-Related from NF2-Related Schwannomatosis - Clinical and Genetic Approaches - Said Farschtschi

Masterclasses in NF: Distinguishing Non-NF2-Related from NF2-Related Schwannomatosis - Clinical and Genetic Approaches

Said Farschtschi, MD, University Medical Center, Hamburg-Eppendorf, Germany

Masterclasses in NF: NF1 Pre-Implantation Genetic Diagnosis - Eric Legius & Prof. Ellen Denayer

Masterclasses in NF: NF1 Pre-Implantation Genetic Diagnosis

Eric Legius, MD, PHD, University Hospital of Leuven, Belgium

Prof. Ellen Denayer, University Hospital of Leuven, Belgium

NF2 Working Together: from a tentative diagnosis and beyond

Understanding the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

NF1 Working Together Part 2: from a tentative diagnosis and beyond

Understanding the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

NF1 Working Together Part 1: from a tentative diagnosis and beyond

Understanding  the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

Masterclasses in NF: Surgery in NF2 - Michel Kalamarides & Andrew King

Masterclasses in NF: Surgery in NF2

Michel Kalamarides, MD, PhD, Hôpital Pitié-Salpêtrière, Paris, France

Prof Andrew King, MBBS FRCS FRCS(SN), Salford Royal Hospital, Manchester, United Kingdom. Member of the MAB of Nerve Tumours UK

Masterclasses in NF: Cognition and Behaviour in NF1: Phenotype and Treatment Approaches - Shruti Garg, Andre Rietman

Masterclasses in NF: Cognition and Behaviour in NF1: Phenotype and Treatment Approaches

Dr Shruti Garg, MBBS, MRCPsych, MMedSci, PhD, Royal Manchester Children’s Hospital, United Kingdom. Member of the MAB of Nerve Tumours UK

Andre Rietman, PhD, Erasmus University Medical Center, Rotterdam, Netherlands

Masterclasses in NF: Emotional Challenges in NF1, NF2 and Schwannomatosis - Susie Henley, Thomas Pletschko & Verena Rosenmayr

Masterclasses in NF: Emotional Challenges in NF1, NF2 and Schwannomatosis

Susie Henley, DClinPsy, PhD, Guy’s and St Thomas’ NHS Foundation Trust, London UK

Thomas Pletschko, PhD, Medical University of Vienna, Austria

Verena Rosenmayr, Clinical Psychologist, Medical University of Vienna, Austria

Masterclasses in NF: NF1 Pediatric Management - Rianne Oostenbrink

Masterclasses in NF: NF1 Pediatric Management

Rianne Oostenbrink, MD, PhD, Erasmus University Medical Center, Rotterdam, Netherlands

Masterclasses in NF: Associated Glioma in Children - the Optic Pathway and Beyond - Amedeo Azizi

Masterclasses in NF: Associated Glioma in Children - the Optic Pathway and Beyond

Amedeo Azizi, MD, PhD, Head of the Paediatric Neurofibromatosis Program and Paediatric Neuro-Oncology Program, Medical University of Vienna, Austria

Masterclasses in NF: NF1 Orthopedic Manifestations - Eric Legius and Christophe Glorion

Masterclasses in NF: NF1 Orthopedic Manifestations

Eric Legius, MD, PhD. Head of Clinical Genetics Department of the University Hospital Leuven, Belgium

Christophe Glorion, MD, PhD, Department of Paediatric Orthopedic and Traumatologic Surgery, Hopital Necker-Enfants Malades, Paris, France. 

Masterclasses in NF: NF1 Malignant Peripheral Nerve Sheath Tumours - Rosalie Ferner and Viktor-Felix Mautner

Masterclasses in NF: NF1 Malignant Peripheral Nerve Sheath Tumours

Prof Rosalie Ferner, Consultant Neurologist and Lead Clinician for Neurofibromatosis, Guy's and St. Thomas' NHS Foundation Trust, London. Member of the MAB of Nerve Tumours UK and Trustee of Nerve Tumours UK

Viktor-Felix Mautner, MD, PhD. University Medical Centre in Hamburg-Eppendorf, Germany. Head of NF Outpatient Department

Masterclasses in NF - Neurofibromatosis Type 1: Cutaneous Neurofibromas - Pierre Wolkenstein and Sirkku Peltonen

Masterclasses in NF - Neurofibromatosis Type 1: Cutaneous Neurofibromas

Pierre Wolkenstein, MD, PhD. Hopital Henri-Mondor, Paris, France. Head of the Department of Dermatology

Sirkku Peltonen MD, PhD. University of Gothenberg, Sweden. Professor of Dermatology

INFER (International NF Educational Resources) is a series of online educational lectures for medical professionals by leading neurofibromatosis experts. The Masterclasses take place online approximately once a month, each on a different topic, and include real-time interaction between the expert presenter and the participants. The presentations are conducted in English, with real-time audio interpretation available in 6 additional languages: French, German, Italian, Portuguese, Russian, and Spanish. A recording of each INFER masterclass is then be made available online in each language for those who could not attend an event. INFER is an initiative of Children’s Tumor Foundation Europe, supported by an educational grant from AstraZeneca. https://ctfeurope.org/research/masterclasses-in-nf

BPNA Keynote Lecture - Prof Rosalie Ferner - Neurofibromatosis 1 in the 21st Century

‘Neurofibromatosis 1 in the 21st Century’

Keynote Lecture at the 48th British Paediatric Neurology Association Annual Scientific Meeting on 21st January 2022

Prof Rosalie Ferner, Consultant Neurologist and Lead Clinician for Neurofibromatosis, Guy's and St. Thomas' NHS Foundation Trust, London. Member of the MAB of Nerve Tumours UK and Trustee of Nerve Tumours UK